Order Article Reprints

Takahashi A, Moriguchi M, Seko Y, Shima T, Mitsumoto Y, Takashima H, Kimura H, Fujii H, Ishikawa H, Yo T, et al. Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis. Cancers. 2020; 12(3):754. https://doi.org/10.3390/cancers12030754

Takahashi, Aya, Michihisa Moriguchi, Yuya Seko, Toshihide Shima, Yasuhide Mitsumoto, Hidetaka Takashima, Hiroyuki Kimura, Hideki Fujii, Hiroki Ishikawa, Takaharu Yo, and et al. 2020. "Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis" Cancers 12, no. 3: 754. https://doi.org/10.3390/cancers12030754

Takahashi, A., Moriguchi, M., Seko, Y., Shima, T., Mitsumoto, Y., Takashima, H., Kimura, H., Fujii, H., Ishikawa, H., Yo, T., Ishiba, H., Morita, A., Jo, M., Nagao, Y., Arai, M., Hara, T., Okajima, A., Muramatsu, A., Yoshinami, N., ... Itoh, Y. (2020). Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis. Cancers, 12(3), 754. https://doi.org/10.3390/cancers12030754